Meeder Asset Management Inc Syros Pharmaceuticals, Inc. Transaction History

Meeder Asset Management Inc

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 09, 2021	SELL	$5.01 - $7.48 $4,589 - $6,851	-916 Closed	0 $0
Q1 2021 Apr 28, 2021	BUY	$7.19 - $14.95 $6,586 - $13,694	916 New	916 $7,000
Q4 2020 Feb 09, 2021	SELL	$6.66 - $14.66 $62,730 - $138,082	-9,419 Closed	0 $0
Q3 2020 Nov 02, 2020	BUY	$8.69 - $14.47 $81,851 - $136,292	9,419 New	9,419 $82,000
Q1 2020 May 15, 2020	SELL	$4.46 - $9.2 $5,463 - $11,270	-1,225 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$4.52 - $10.1 $4,660 - $10,413	1,031 Added 531.44%	1,225 $8,000
Q3 2019 Oct 17, 2019	BUY	$7.14 - $11.65 $1,385 - $2,260	194 New	194 $2,000
Q2 2019 Aug 05, 2019	SELL	$5.5 - $9.75 $1,512 - $2,681	-275 Closed	0 $0
Q1 2019 Apr 16, 2019	SELL	$5.51 - $9.59 $1,708 - $2,972	-310 Reduced 52.99%	275 $3,000
Q4 2018 Jan 17, 2019	BUY	$5.55 - $11.34 $2,652 - $5,420	478 Added 446.73%	585 $3,000
Q3 2018 Nov 02, 2018	SELL	$9.74 - $12.92 $107 - $142	-11 Reduced 9.32%	107 $0
Q2 2018 Jul 24, 2018	SELL	$10.16 - $13.65 $233 - $313	-23 Reduced 16.31%	118 $0
Q1 2018 May 03, 2018	SELL	$9.47 - $12.98 $1,950 - $2,673	-206 Reduced 59.37%	141 $2,000
Q4 2017 Feb 02, 2018	BUY	$8.45 - $17.48 $2,501 - $5,174	296 Added 580.39%	347 $3,000
Q3 2017 Oct 20, 2017	BUY	$13.52 - $23.75 $689 - $1,211	51	51 $1,000

Ticker SYRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,236,200
Market Cap $43.1M
Description
Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatments for cancer and monogenic diseases, and building a pipeline of gene control medicines. The company's lead product candidates are Tamibarotene, a selective retinoic acid receptor alpha agonist, which is in Phase III clinical trial for genomically def...

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Meeder Asset Management Inc with notifications on news.